52-209-2-Prohibition-on-Contracting-with-Inverted-Domestic-Corporations-Representation-.pdf
PDF 47 KB Posted
- Attached to
- Gene Synthesis expression and purification
- Solicitation number
- 12405B24Q0116
About this file
This request for quotation solicits proposals for the expression and purification of five recombinant mouse IgE monoclonal antibodies recognizing nut allergens. Offerors must produce plasmids encoding the heavy and light chains of the antibodies, express the antibodies in CHO cells, and purify each using protein A/G. The antibodies must distinguish between the nut allergens Ana o 3 and Car i 1 by ELISA and immunoblot. Proposals are due by March 15, 2024 and must include a quote, representations and certifications, and delivery within 30 days after award. Evaluation will be based on technical capability, past performance, and price with technical factors being most important. Award will be made to the offeror providing the most advantageous solution meeting requirements. The soliciting agency is the Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
52.209-2 Prohibition on Contracting with Inverted Domestic Corporations- Representation.
As prescribed in 9.108-5(a), insert the following provision:
Prohibition on Contracting with Inverted Domestic Corporations-Representation (Nov 2015)
(a) Definitions. "Inverted domestic corporation" and "subsidiary" have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10).
(b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4.
(c) Representation. The Offeror represents that-
(1) It □ is, □ is not an inverted domestic corporation; and
(2) It □ is, □ is not a subsidiary of an inverted domestic corporation.
(End of provision)
Parent topic: 52.209 [Reserved] https://www.acquisition.gov/far/9.108-5#FAR_9_108_5 https://www.acquisition.gov/far/52.209-10#FAR_52_209_10 https://www.acquisition.gov/far/9.108-2#FAR_9_108_2 https://www.acquisition.gov/far/9.108-4#FAR_9_108_4 https://www.acquisition.gov/far/52.209
File details come from the government source that posted it. Updated .